Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Generic brand for latisse?How does protein binding influence lipitor's removal via kidneys?Patent expiration date of guselkumab?Defense strategy against generic in niche market?What condition primarily benefits from sapropterin therapy?
See the DrugPatentWatch profile for keytruda
Pembrolizumab (Keytruda) received its FDA approval on September 4, 2014 for advanced melanoma (initial indication). Sources: 1. https://www.fda.gov/drugs/resources-information-approved-drugs/infographic-fda-approvals-pembrolizumab-keytruda
Other Questions About Keytruda :